Acquired Haemophilia: An Update
Aktuelle Rheumatologie, ISSN: 1438-9940, Vol: 47, Issue: 6, Page: 502-505
2022
- 2Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Acquired haemophilia A is the most common form of inhibitor-induced aquired haemophilia. It can occur idiopathically, in association with other diseases or post partum. In the majority of cases, there are pronounced bleeding signs that can be life-Threatening. Important differential diagnoses are mentioned. The diagnosis is made on the basis of prolonged aPTT by plasma mixing tests and the Bethesda test. As treatment, local measures, coagulation factor preparations and tranexamic acid are used to stop bleeding, and immunosuppression with glucocorticoids, rituximab and cyclophosphamide to eliminate the inhibitory autoantibody. Further immunosuppressive treatment options to treat refractory cases are mentioned. Prognosis seems to depend mainly on the extent to which factor VIII is initially reduced.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85137399586&origin=inward; http://dx.doi.org/10.1055/a-1876-2742; http://www.thieme-connect.de/DOI/DOI?10.1055/a-1876-2742; https://dx.doi.org/10.1055/a-1876-2742; https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-1876-2742
Georg Thieme Verlag KG
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know